Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC and Metformin for AGE Levels in Prostate Cancer
NCT02946996Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2016
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of opicapone in prostate cancer (PCa) (3 arms), sponsored by Medical University of South Carolina. Primary endpoint: Advanced Glycation Endproducts Level Reduction at 85 days. Started Dec 2016; status: terminated.
02
Drugs
opicapone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02946996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946996.